| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
18,740,000 |
| Market
Cap: |
46.66(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$1.53 - $4.4 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : 5.8 |
| Insider 3/6 Months : 6.4 |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile DiaMedica Therapeutics is a biopharmaceutical company engaged in developing novel therapeutic products to improve the lives of people with Type 1 diabetes, Type 2 diabetes and other significant diseases with unmet medical needs.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
20,000 |
1,667,889 |
5,405,460 |
| Total Buy Value |
$0 |
$49,200 |
$5,742,445 |
$10,565,177 |
| Total People Bought |
0 |
1 |
7 |
8 |
| Total Buy Transactions |
0 |
1 |
8 |
21 |
| Total Shares Sold |
0 |
0 |
0 |
2,855,847 |
| Total Sell Value |
$0 |
$0 |
$0 |
$3,526,971 |
| Total People Sold |
0 |
0 |
0 |
1 |
| Total Sell Transactions |
0 |
0 |
0 |
1 |
| End Date |
2024-01-18 |
2023-10-17 |
2023-04-18 |
2022-04-18 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Alcorn Harry W Jr |
SVP, Clinical Operations |
• – – |
2021-09-15 |
4 |
B |
$3.80 |
$56,960 |
D/D |
15,000 |
43,582 |
2.74 |
-38% |
|
| Pilnik Richard D. |
Director |
– • – |
2021-08-16 |
4 |
B |
$3.21 |
$49,064 |
D/D |
15,000 |
95,565 |
2.39 |
4% |
|
| Burroughs Amy L. |
Director |
– • – |
2021-08-16 |
4 |
B |
$3.15 |
$141,593 |
D/D |
44,950 |
44,950 |
2.39 |
4% |
|
| Kellen Scott |
CFO and Secretary |
• – – |
2021-08-16 |
4 |
B |
$3.15 |
$31,463 |
D/D |
10,000 |
22,290 |
2.74 |
4% |
|
| Pauls Dietrich John |
President and CEO |
• • – |
2021-08-16 |
4 |
B |
$3.14 |
$15,700 |
D/D |
5,000 |
35,804 |
2.81 |
4% |
|
| Alcorn Harry W Jr |
Senior VP, Clinical Operations |
• – – |
2021-08-16 |
4 |
B |
$3.07 |
$1,225 |
I/I |
399 |
399 |
1.91 |
4% |
|
| Alcorn Harry W Jr |
Senior VP, Clinical Operations |
• – – |
2021-08-16 |
4 |
B |
$3.06 |
$62,829 |
D/D |
20,322 |
28,582 |
2.74 |
4% |
|
| Giuffre Randall Michael |
Director |
– • – |
2020-11-20 |
4 |
B |
$4.26 |
$63,912 |
D/D |
15,000 |
108,588 |
2.39 |
131% |
|
| Kellen Scott |
CFO and Secretary |
• – – |
2020-11-09 |
4 |
B |
$4.19 |
$8,387 |
D/D |
2,000 |
12,290 |
2.74 |
144% |
|
| Giuffre Randall Michael |
Director |
– • – |
2020-06-01 |
4 |
A |
$4.59 |
$35,729 |
D/D |
7,784 |
93,588 |
|
- |
|
| Pilnik Richard D. |
Director |
– • – |
2020-06-01 |
4 |
A |
$4.59 |
$46,671 |
D/D |
10,168 |
60,846 |
|
- |
|
| Parsons James T. |
Director |
– • – |
2020-06-01 |
4 |
A |
$4.59 |
$37,188 |
D/D |
8,102 |
14,202 |
|
- |
|
12 Records found
|
1
|
Page 1 of 1 |
|
|
0.12 (5.06%) 
